MidFirst Bank Takes Position in Corteva, Inc. $CTVA

MidFirst Bank bought a new stake in Corteva, Inc. (NYSE:CTVA) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 19,133 shares of the company’s stock, valued at approximately $1,282,000.

Other hedge funds have also added to or reduced their stakes in the company. Annis Gardner Whiting Capital Advisors LLC lifted its position in Corteva by 9.1% during the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 1,674 shares of the company’s stock valued at $112,000 after purchasing an additional 140 shares during the period. Drive Wealth Management LLC grew its position in shares of Corteva by 3.8% during the 4th quarter. Drive Wealth Management LLC now owns 4,259 shares of the company’s stock worth $285,000 after buying an additional 156 shares during the period. Reynders McVeigh Capital Management LLC boosted its stake in Corteva by 2.9% in the fourth quarter. Reynders McVeigh Capital Management LLC now owns 5,686 shares of the company’s stock valued at $381,000 after acquiring an additional 160 shares during the last quarter. Chesapeake Capital Corp IL grew its holdings in Corteva by 0.9% during the 4th quarter. Chesapeake Capital Corp IL now owns 18,035 shares of the company’s stock worth $1,209,000 after acquiring an additional 161 shares during the period. Finally, Fox Run Management L.L.C. grew its holdings in Corteva by 5.1% during the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after acquiring an additional 164 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of CTVA stock opened at $78.57 on Friday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The firm has a market capitalization of $52.55 billion, a price-to-earnings ratio of 46.22, a price-to-earnings-growth ratio of 2.40 and a beta of 0.57. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. The firm has a fifty day moving average of $79.64 and a 200-day moving average of $75.69.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Monday, June 1st. Corteva’s payout ratio is 42.35%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Jefferies Financial Group increased their price target on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Zacks Research cut Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Mizuho upped their price objective on Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Rothschild & Co Redburn increased their target price on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Finally, Citigroup boosted their target price on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $88.81.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.